Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 06-2013 | 12-2012 | 06-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,111 | N/A | 640 | N/A | 1,550 |
| Receivables | 43 | N/A | 0 | N/A | 0 |
| Other current assets | 1,070 | 0 | 1,290 | 0 | 1,660 |
| TOTAL | $7,224 | $N/A | $1,930 | $N/A | $3,210 |
| Non-Current Assets | |||||
| PPE Net | 224 | N/A | 6 | N/A | 7 |
| Other Non-Current Assets | 0 | 0 | 3,515 | 0 | 3,635 |
| TOTAL | $224 | $N/A | $3,521 | $N/A | $3,642 |
| Total Assets | $33,335 | $N/A | $5,460 | $N/A | $6,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 1,080 | 0 | 440 |
| Accrued Expenses | 0 | N/A | 460 | N/A | 800 |
| TOTAL | $1,825 | $N/A | $3,750 | $N/A | $3,440 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 130 | 0 | 570 |
| TOTAL | $N/A | $N/A | $130 | $N/A | $570 |
| Total Liabilities | $5,845 | $N/A | $3,880 | $N/A | $4,020 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 1,170 | N/A | 800 |
| Retained earnings | -88,280 | N/A | -71,440 | N/A | -64,350 |
| Other shareholders' equity | 115,770 | 0 | 0 | 0 | 10 |
| TOTAL | $27,490 | $N/A | $1,580 | $N/A | $2,830 |
| Total Liabilities And Equity | $33,335 | $0 | $5,460 | $0 | $6,850 |